DNA Ginkgo Bioworks
- 0.773
- -0.147-15.93%
Ginkgo Bioworks News
William Blair: Downgraded the Ginkgo Bioworks Holdings (DNA.US) rating from a unanimous market to lower than the market rating.
William Blair: Downgraded the Ginkgo Bioworks Holdings (DNA.US) rating from a unanimous market to lower than the market rating.
Ginkgo Bioworks Holdings Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 — William Blair Downgrades Market Perform → Underperform 03/01/2024 270.37% TD Cowen $7 → $3 M
William Blair Downgrades Ginkgo Bioworks Holdings to Underperform From Market Perform
Ginkgo Bioworks Holdings (DNA) has an average investment rating of hold among analysts polled by Capital IQ, with price targets ranging from $1 to $3. Price: 0.8073, Change: -0.11, Percent Change: -12
Akamai Technologies Issues Weak Outlook, Joins Applied Optoelectronics, JFrog And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday.Shares of Akamai Technologies, Inc. (NASDAQ:AKAM) fell sharply in today's pre-market trading after
Earnings Call Summary | Ginkgo Bioworks(DNA.US) Q1 2024 Earnings Conference
The following is a summary of the Ginkgo Bioworks Holdings, Inc. (DNA) Q1 2024 Earnings Call Transcript:Financial Performance:Ginkgo Bioworks Q1 2024 revenue was $38 million, down by 18% compared to Q
Ginkgo Bioworks Holdings Q1 Loss Narrows, Revenue Drops; 2024 Revenue Outlook Slashed; Cost Cuts Planned
Ginkgo Bioworks Holdings (DNA) reported a Q1 loss Thursday of $0.08 per diluted share, compared with the loss of $0.11 a year earlier. Analysts polled by Capital IQ expected a loss of $0.08. Revenue i
Ginkgo Bioworks Files to Sell 18.86M Shares for Holders
Ginko Bioworks Holdings Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Sales Results.
Ginko Bioworks Holdings Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Sales Results.
Ginkgo Bioworks Stock Falls On Disappointing Q1 Sales: 'This Trend Needs To Change'
Ginkgo Bioworks Holdings, Inc. (NASDAQ:DNA) reported its first-quarter financial results after the bell Thursday. Here's a look at the key figures from the report. The Details:Ginkgo Bioworks reported
Ginkgo Bioworks | 10-Q: Quarterly report
Earnings Flash (DNA) GINKGO BIOWORKS Posts Q1 Revenue $38M, Vs. Street Est of $46M
04:14 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (DNA) GINKGO BIOWORKS Posts Q1 Revenue $38M, vs. Street Est of $46M
Ginkgo Bioworks Holdings 1Q Rev $37.9M >DNA
Ginkgo Bioworks Holdings 1Q Rev $37.9M >DNA
Ginkgo Bioworks Holdings Q1 Sales $38.000M Miss $46.044M Estimate
Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly sales of $38.000 million which missed the analyst consensus estimate of $46.044 million by 17.47 percent. This is a 52.91 percent decrease over
Ginkgo Bioworks, GreenLab Launch Partnership to Produce Sugar Substitute Brazzein
Ginkgo Bioworks (DNA) and GreenLab said Tuesday they are launching a new partnership to produce the sweetener brazzein at commercial scale. Brazzein is a protein found in the fruit of the Oubli plant,
Recent Uptick Might Appease Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Institutional Owners After Losing 25% Over the Past Year
Ginkgo Bioworks: Buy, Sell, or Hold?
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister it
Ginkgo Bioworks Surges as Much as 31%, Though Pares Gains
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Nasdaq Composite jumping over 50 points on Monday.Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply during Monday's session on reports the company will partner with Ba
Looking Into Ginkgo Bioworks Holdings's Recent Short Interest
Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has risen 3.26% since its last report. The company recently reported that it has 270.83 million shares sold short, which is 19.94% of all r
Analysis
Price Target
No Data
